Page last updated: 2024-09-05

succinobucol and Acute Coronary Syndrome

succinobucol has been researched along with Acute Coronary Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gómez, G; Lagakos, SW	1
Horowitz, J; Kaski, JC; McMurray, JJ; Recio-Mayoral, A; Remme, WJ; van Veldhuisen, DJ	1
Choi, J; Cooper, J; Klug, E; L'Allier, PL; Lewis, EF; McMurray, JJ; Pfeffer, MA; Schumi, J; Scott, R; Small, R; Tardif, JC	1

Trials

1 trial(s) available for succinobucol and Acute Coronary Syndrome

Article	Year
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet (London, England), 2008, May-24, Volume: 371, Issue:9626 Topics: Acute Coronary Syndrome; Adult; Aged; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Endpoint Determination; Female; Humans; Male; Middle Aged; Probucol	2008

Other Studies

2 other study(ies) available for succinobucol and Acute Coronary Syndrome

Article	Year
Statistical considerations when using a composite endpoint for comparing treatment groups. Statistics in medicine, 2013, Feb-28, Volume: 32, Issue:5 Topics: Acute Coronary Syndrome; AIDS Vaccines; Anti-HIV Agents; Anticholesteremic Agents; Biostatistics; Endpoint Determination; HIV Infections; Humans; Probucol; Randomized Controlled Trials as Topic	2013
Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY. Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:6 Topics: Abciximab; Acute Coronary Syndrome; Amides; Antibodies, Monoclonal; Benzazepines; Clinical Trials as Topic; Clopidogrel; Electrocardiography; Europe; Fumarates; Heart Diseases; Heart Failure; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptide Fragments; Probucol; Recombinant Proteins; Ticlopidine; Tolvaptan	2007

Article

Year

Statistical considerations when using a composite endpoint for comparing treatment groups.

Statistics in medicine, 2013, Feb-28, Volume: 32, Issue:5

Topics: Acute Coronary Syndrome; AIDS Vaccines; Anti-HIV Agents; Anticholesteremic Agents; Biostatistics; Endpoint Determination; HIV Infections; Humans; Probucol; Randomized Controlled Trials as Topic

2013

Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.

Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:6

Topics: Abciximab; Acute Coronary Syndrome; Amides; Antibodies, Monoclonal; Benzazepines; Clinical Trials as Topic; Clopidogrel; Electrocardiography; Europe; Fumarates; Heart Diseases; Heart Failure; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptide Fragments; Probucol; Recombinant Proteins; Ticlopidine; Tolvaptan

2007